Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole

Transpl Infect Dis. 2004 Mar;6(1):37-40. doi: 10.1111/j.1399-3062.2004.00039.x.

Abstract

We describe the rare case of a diabetic patient who was successfully treated for cytomegalovirus viremia and leishmaniasis following liver transplantation for hepatitis C virus-related cirrhosis, but also developed invasive sinus Aspergillus infection, while still on liposomal amphotericin B (AmBisome). The patient refused radical surgery including eye enucleation, and received a combination of intravenous caspofungin and voriconazole, along with repeated, conservative, local surgical debridement. At follow-up, 15 months after the onset of sinusitis, the patient remains culture-negative, fully active, and without evidence of local recurrence.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use*
  • Aspergillosis / drug therapy*
  • Aspergillosis / microbiology
  • Caspofungin
  • Echinocandins
  • Female
  • Humans
  • Lipopeptides
  • Liver Transplantation / adverse effects*
  • Peptides / therapeutic use*
  • Peptides, Cyclic*
  • Pyrimidines / therapeutic use*
  • Sinusitis / drug therapy*
  • Sinusitis / microbiology
  • Treatment Outcome
  • Triazoles / therapeutic use*
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides
  • Peptides, Cyclic
  • Pyrimidines
  • Triazoles
  • Caspofungin
  • Voriconazole